Verition Fund Management LLC Tango Therapeutics, Inc. Transaction History
Verition Fund Management LLC
- $21.7 Billion
- Q3 2025
A detailed history of Verition Fund Management LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 24,752 shares of TNGX stock, worth $191,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,752Holding current value
$191,085% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding TNGX
# of Institutions
143Shares Held
124MCall Options Held
215KPut Options Held
33.8K-
Trv Gp Iv, LLC Boston, MA13.9MShares$107 Million100.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.8MShares$83 Million0.39% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$82.9 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$82.1 Million6.71% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$46.6 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $680M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...